DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bowen, W. P.
Right arrow Articles by Brown, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bowen, W. P.
Right arrow Articles by Brown, A. M.

Vol. 28, Issue 7, 781-788, July 2000

Measurement of Cytochrome P450 Gene Induction in Human Hepatocytes using Quantitative Real-Time Reverse Transcriptase-Polymerase Chain Reaction

Wayne P. Bowen, Jae E. Carey, Asik Miah, Heather F. McMurray, Peter W. Munday, Rowena S. James, Robert A. Coleman, and Anthony M. Brown

Pharmagene plc, Orchard Road, Royston, Hertfordshire, United Kingdom

Drug-induced changes in expression of cytochrome (CYP) P450 genes are a key cause of drug-drug interactions. Consequently, preclinical prediction of these changes by novel compounds is an integral component of drug development. To date, in vitro models of CYP induction have used mRNA measurement, immunodetection, and substrate metabolism as reporters. Here, we describe the application of quantitative real-time reverse transcriptase polymerase chain reaction to study CYP1A1 and CYP3A4 gene induction in 5-day-old cultures of human hepatocytes by known CYP inducers. After 5 days in culture, CYP1A1 expression was significantly elevated (5.1- to 26-fold; P < .01) in all four livers studied. In direct contrast, CYP3A4 mRNA levels consistently decreased during culture (80- to 300-fold; P < .001). In three independent experiments, a 48-h exposure to 3-methylcholanthrene, omeprazole, and lansoprazole significantly induced CYP1A1 expression in comparison to untreated cultures (P < .05). Rifampicin and solvent were without effect on CYP1A1 expression. Under identical experimental conditions, rifampicin and lansoprazole significantly elevated CYP3A4 mRNA expression (P < .05), whereas 3-methylcholanthrene, omeprazole, and dimethyl sulfoxide were without significant effect. These data demonstrate the applicability of quantitative reverse transcriptase polymerase chain reaction to the determination of gene dynamics in human hepatocytes. This offers a highly specific alternative to quantification of drug effects on CYP expression using immunodetection and substrate metabolism.

Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
T. Johansson, U. Jurva, G. Gronberg, L. Weidolf, and C. Masimirembwa
Novel Metabolites of Amodiaquine Formed by CYP1A1 and CYP1B1: Structure Elucidation Using Electrochemistry, Mass Spectrometry, and NMR
Drug Metab. Dispos., March 1, 2009; 37(3): 571 - 579.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. S. Sane, D. J. Buckley, A. R. Buckley, S. C. Nallani, and P. B. Desai
Role of Human Pregnane X Receptor in Tamoxifen- and 4-Hydroxytamoxifen-Mediated CYP3A4 Induction in Primary Human Hepatocytes and LS174T Cells
Drug Metab. Dispos., May 1, 2008; 36(5): 946 - 954.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
G. I. Somers, N. Lindsay, B. M. Lowdon, A. E. Jones, C. Freathy, S. Ho, A. J. M. Woodrooffe, M. K. Bayliss, and G. R. Manchee
A Comparison of the Expression and Metabolizing Activities of Phase I and II Enzymes in Freshly Isolated Human Lung Parenchymal Cells and Cryopreserved Human Hepatocytes
Drug Metab. Dispos., October 1, 2007; 35(10): 1797 - 1805.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
J. Li, M. Zhao, P. He, M. Hidalgo, and S. D. Baker
Differential Metabolism of Gefitinib and Erlotinib by Human Cytochrome P450 Enzymes
Clin. Cancer Res., June 15, 2007; 13(12): 3731 - 3737.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. Lindeberg, K. Carlstrom, O. Ritvos, and O. Hovatta
Gonadotrophin stimulation of non-luteinized granulosa cells increases steroid production and the expression of enzymes involved in estrogen and progesterone synthesis
Hum. Reprod., February 1, 2007; 22(2): 401 - 406.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S. J. Baldwin, J. L. Bramhall, C. A. Ashby, L. Yue, P. R. Murdock, S. R. Hood, A. D. Ayrton, and S. E. Clarke
CYTOCHROME P450 GENE INDUCTION IN RATS EX VIVO ASSESSED BY QUANTITATIVE REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION (TAQMAN)
Drug Metab. Dispos., June 1, 2006; 34(6): 1063 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
X. Zhuo, N. Zheng, C. A. Felix, and I. A. Blair
KINETICS AND REGULATION OF CYTOCHROME P450-MEDIATED ETOPOSIDE METABOLISM
Drug Metab. Dispos., September 1, 2004; 32(9): 993 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
R. J. Davis, K. J. Page, G. J. Dos Santos Cruz, D. W. Harmer, P. W. Munday, S. J. Williams, J. Picot, T. J. Evans, R. L. Sheldrick, R. A. Coleman, et al.
Expression and Functions of the Duodenal Peptide Secretin and its Receptor in Human Lung
Am. J. Respir. Cell Mol. Biol., September 1, 2004; 31(3): 302 - 308.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Tateno, Y. Yoshizane, N. Saito, M. Kataoka, R. Utoh, C. Yamasaki, A. Tachibana, Y. Soeno, K. Asahina, H. Hino, et al.
Near Completely Humanized Liver in Mice Shows Human-Type Metabolic Responses to Drugs
Am. J. Pathol., September 1, 2004; 165(3): 901 - 912.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
B. J. Komoroski, S. Zhang, H. Cai, J. M. Hutzler, R. Frye, T. S. Tracy, S. C. Strom, T. Lehmann, C. Y. W. Ang, Y. Y. Cui, et al.
INDUCTION AND INHIBITION OF CYTOCHROMES P450 BY THE ST. JOHN'S WORT CONSTITUENT HYPERFORIN IN HUMAN HEPATOCYTE CULTURES
Drug Metab. Dispos., May 1, 2004; 32(5): 512 - 518.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Anakk, C. Y. Ku, M. Vore, and H. W. Strobel
Insights into Gender Bias: Rat Cytochrome P450 3A9
J. Pharmacol. Exp. Ther., May 1, 2003; 305(2): 703 - 709.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. P. Basten, Y. Bao, and G. Williamson
Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells
Carcinogenesis, August 1, 2002; 23(8): 1399 - 1404.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. M. Rae, M. D. Johnson, M. E. Lippman, and D. A. Flockhart
Rifampin Is a Selective, Pleiotropic Inducer of Drug Metabolism Genes in Human Hepatocytes: Studies with cDNA and Oligonucleotide Expression Arrays
J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 849 - 857.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. E. Burczynski, M. McMillian, J. B. Parker, S. Bryant, A. Leone, E. R. Grant, J. M. Thorne, Z. Zhong, R. A. Zivin, and M. D. Johnson
Cytochrome P450 Induction in Rat Hepatocytes Assessed by Quantitative Real-Time Reverse-Transcription Polymerase Chain Reaction and the RNA Invasive Cleavage Assay
Drug Metab. Dispos., September 1, 2001; 29(9): 1243 - 1250.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.